During CytoJournal editorial board activity in 2007 corresponding
with USCAP annual meeting at San Diego the Editorial board
members along with other ad-hoc scholars decided that
‘CytoJournal Monograph & Atlas Series (CMAS)’ will be a great
opportunity for cytopathology scholars to contribute and
disseminate their work under 'Open Access charter’ without
losing the copyright to their work.
This is especially an excellent opportunity for highly
competitive and productive budding junior stalwarts with
participation from established veterans to share their
leadership. CytoJournal will try to find avenues to involve as
many people of wider spectrum as possible. At this brainstorming
stage, the group suggested a few ways of achieving this.
The benefits of the project (to be mentioned a few) are-
- Authors retain their copyright.
- Authors work is not lost from Public Domain
- Both junior and senior authors get the benefits.
- Readers get the peer-reviewed material.
- We expect the cost to be significantly lower than commercial
alternatives.
Each monograph/Atlas should contain the following
- Brief description of the background and salient features of
entities.
- The focus should be mainly on differential diagnosis and
surgical pathology counterparts with role of special studies (immuno,
molecular and new trends).
- The clinical pathologic correlation and some account of
clinical management (we can always include some clinicians in
few such as thyroid, Urine, and respiratory) and investigation
(role of ultrasound, CT or MRI).
- Should be heavily illustrated with sketches as indicated.
Each CytoJournal Monograph/Atlas will be:
- Up to 100 printed pages (letter size).
- Will have 4 to 5 chapters with first introductory chapter
connecting all chapters in the monograph/atlas.
- Each chapter should be stand-alone and will be initially
published as CytoJournal article (with note that it is one of
the chapters from particular CMAS)
- After all the articles are published in CytoJournal, the
monograph will be available in print form through on-line
subscription to different types of members and for general sale
through any vendr(s).
- The monographs should be updated in future depending on the
scientific and standard of practice changes in the field, as
judged by the editorial board with input from readers.
The current editorial structure for the CMAS project
is as follows:
CMAS Committee:
(The central force in executing this project with the input from
CytoJournal Executive editor)
Co-chairs
Shikha Bose, MD (Cedars-Sinai Medical Center)
Zubair Baloch, MD, PhD (University of Pennsylvania Medical
Center)
Members: (Up to 3, to be updated soon)
CMAS coeditors-in-chief
David C. Wilbur, MD (Harvard Medical School / Mass Gen Hosp)
R. Marshal Austin, MD, PhD (University of Pittsburgh Medical
Center)
Ruth Katz, MD (MD Anderson Cancer Center)
CytoJournal Coeditors-in-chief
Barbara F. Atkinson, MD (University of Kansas School of
Medicine)
Vinod B. Shidham, MD, FRCPath, FIAC (Medical College of
Wisconsin
CytoJournal Executive editor
Vinod B. Shidham, MD, FRCPath, FIAC (Medical College of
Wisconsin
Each Monograph has ‘editor(s)’ with a team of
‘Contributing Authors’ selected by that ‘editor(s)’ for that
Monograph.
Each Monograph has ‘Academic editor(s)’ with a team of
“Peer-reviewers” selected by that ‘‘Academic editor(s)’.
One of the strengths of CMAS is its peer-reviewed status.
‘‘Academic editor’ is selected by CMAS Committee Co-chairs in
consultation with CMAS coeditors-in-chief, CytoJournal
Coeditors-in-chief, and CytoJournal Executive editor. The
‘Academic editor’ with participating peer-reviewers will be
acknowledged and thanked for their efforts as a part of that
monograph/atlas’s editorial team.
To achieve practical flexibility we should keep the list open
and let individual monograph/atlas editors to select the topics.
We will number them in chronological order as and when they are
complete (E. g. CMAS# 1, CMAS# 2, & so on). The CMAS committee
would steer the possible chapters and identify potential
monograph editors on ongoing basis. Qualified experts and group
of experts are encouraged to contact and propose the
monograph/atlas on different topics in cytopathology. Below is
the tentative list prepared by Dr. Zubair Baloch as a starter.
It is categorized by organ system. They will be published on
first-come/first-finalized basis subject to the quality and CMAS
editorial decision based on peer-review process. We will use it
for tracking the topics but the order is subject to
modifications.
The current tentative CMAS list is as follows (this is
incomplete and subject to modifications):
Head and Neck
- Thyroid & Parathyroid-
- Salivary Gland and other head & Neck structures
Fluids
GI Tract
- GI tract EUS guided- Pancreas
- Liver
- Anal cytology
Respiratory tract
Lymph nodes
GYN Cytology
Pediatric Cytopathology
Litigation in cytopathology and quality assurance issues
OtherFNAB procedure- Art & Science
GI tract EUS guided- Other
Kidney and Adrenal –
Other deep seated organs
Brief details for the editors of the individual
monograph/atlas-
The proposal for any topic for CMAS (including those in the list
above) may be sent to
cytojournal@mcw.edu.
The editor(s) of individual CMAS would enjoy royalty sharing for
sale of printed version of their monograph/atlas with
Cytopathology Foundation Inc after crossing the break-even point
for the project. Such royalty may be donated as tax deductible
donation to Cytopathology Foundation Inc (non-profit entity) to
further similar future projects for open access in cytopathology.
|
